Zoetis Inc. (ZTS)

NYSE: ZTS · Real-Time Price · USD
175.32
-1.62 (-0.92%)
Dec 4, 2024, 4:00 PM EST - Market closed
-0.92%
Market Cap 79.10B
Revenue (ttm) 9.15B
Net Income (ttm) 2.43B
Shares Out 451.17M
EPS (ttm) 5.32
PE Ratio 32.97
Forward PE 28.40
Dividend $1.73 (0.99%)
Ex-Dividend Date Oct 31, 2024
Volume 2,686,223
Open 174.60
Previous Close 176.94
Day's Range 174.54 - 178.50
52-Week Range 144.80 - 201.92
Beta 0.88
Analysts Strong Buy
Price Target 219.00 (+24.91%)
Earnings Date Nov 4, 2024

About ZTS

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives... [Read more]

Sector Healthcare
IPO Date Feb 1, 2013
Employees 14,100
Stock Exchange NYSE
Ticker Symbol ZTS
Full Company Profile

Financial Performance

In 2023, Zoetis's revenue was $8.54 billion, an increase of 5.74% compared to the previous year's $8.08 billion. Earnings were $2.34 billion, an increase of 10.88%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for ZTS stock is "Strong Buy." The 12-month stock price forecast is $219.0, which is an increase of 24.91% from the latest price.

Price Target
$219.0
(24.91% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Zoetis Inc. (ZTS) Piper Sandler 36th Annual Healthcare Conference (Transcript)

Zoetis Inc. (NYSE:ZTS) Piper Sandler 36th Annual Healthcare Conference Call December 3, 2024 11:30 AM ET Company Participants Wetteny Joseph - Chief Financial Officer Conference Call Participants Dav...

10 hours ago - Seeking Alpha

My Top 15 High-Growth Dividend Stocks For December 2024

The SPDR S&P 500 ETF Trust posted a strong gain of 5.96% in November, resuming its strong run in 2024. The Top 15 dividend growth stocks for December 2024 offer an average dividend yield of 1.2% and a...

Other symbols: ACNAPHCNIDPZELVGPNINTU
2 days ago - Seeking Alpha

Zoetis: Healing Paws, Growing Profits

Zoetis is active in multiple segments that are all expected to grow at a CAGR of 4% or more. The company has growing revenues, a strong balance sheet, a high FCF margin, and no major maturities. Libre...

5 days ago - Seeking Alpha

Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)

Zoetis Inc. (NYSE:ZTS) Jefferies London Healthcare Conference November 20, 2024 10:00 AM ET Company Participants Wetteny Joseph - CFO Conference Call Participants Glen Santangelo - Jefferies Glen San...

14 days ago - Seeking Alpha

Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024. Wetteny Joseph, E...

15 days ago - Business Wire

Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy

Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO, outperforming the S&P 500. The company benefits from increasing global pet ownership and spending...

16 days ago - Seeking Alpha

Zoetis: The Major Player in the $500B Pet Market You May Not Have Heard Of

The pet industry is growing fast and could reach a global market size of half a trillion dollars by 2032. This episode looks at why people bought more pets during COVID, the trend of treating pets lik...

22 days ago - After Earnings

Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role

PARSIPPANY, N. J.--(BUSINESS WIRE)--ZOETIS APPOINTS JAMIE BRANNAN TO NEWLY CREATED CHIEF COMMERCIAL OFFICER ROLE.

23 days ago - Business Wire

Zoetis Q3: Strong Osteoarthritis Pain Franchise

I reiterate a 'Buy' rating for Zoetis with a one-year target price of $210 per share, driven by strong product performance and strategic divestitures. The Company's osteoarthritis drugs, LIBRELA and S...

23 days ago - Seeking Alpha

Zoetis to Participate in Jefferies London Healthcare Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Wetteny Joseph, Executi...

27 days ago - Business Wire

Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript

Zoetis Inc. (NYSE:ZTS) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Steve Frank - VP of IR Kristin Peck - CEO Wetteny Joseph - CFO Conference Call Participants Er...

4 weeks ago - Seeking Alpha

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Zoetis Inc. For Fraud

LOS ANGELES, CA / ACCESSWIRE / November 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

4 weeks ago - Accesswire

Zoetis raises annual forecasts on strong demand for pet treatments

Zoetis raised its annual profit and revenue forecasts on Monday on strong demand for its medicines and vaccines for animals.

4 weeks ago - Reuters

Zoetis Announces Third Quarter 2024 Results

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2024 and raised its full year 2024 guidance for revenue a...

4 weeks ago - Business Wire

My Top 15 High-Growth Dividend Stocks For November 2024

The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% an...

4 weeks ago - Seeking Alpha

Zoetis Inc Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

4 weeks ago - Accesswire

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Zoetis Inc. For Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

4 weeks ago - Accesswire

Phibro Animal Health Corporation Completes Acquisition of Zoetis' Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the successful completion of the acquisition of the medicated feed additive product portfolio and certai...

Other symbols: PAHC
4 weeks ago - Business Wire

Zoetis Inc Is Being Investigated For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESSWIRE / October 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

4 weeks ago - Accesswire

Investors Are Invited To Join The Schall Law Firm's Inquiry Into Zoetis Inc. For Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / October 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

5 weeks ago - Accesswire

Zoetis Inc Is Being Investigated For Securities Related Infractions And The Schall Law Firm Urges Impacted Shareholders To Reach Out

LOS ANGELES, CA / ACCESSWIRE / October 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

5 weeks ago - Accesswire

Zoetis Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part

LOS ANGELES, CA / ACCESSWIRE / October 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

5 weeks ago - Accesswire

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Zoetis Inc. For Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / October 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

5 weeks ago - Accesswire

Zoetis Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESSWIRE / October 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

5 weeks ago - Accesswire

Zoetis Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part

LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...

6 weeks ago - Accesswire